167631-50-7

Usage

Uses

Used in Pharmaceutical Synthesis:
5-FLUORO-1-METHYL-1H-INDOLE-2-CARBOXYLIC ACID is utilized as a key building block in the creation of pharmaceutical compounds. Its unique structure allows for the development of new drugs with specific therapeutic properties.
Used in Research Chemicals:
5-FLUORO-1-METHYL-1H-INDOLE-2-CARBOXYLIC ACID is also employed in the synthesis of research chemicals, facilitating the exploration of new chemical reactions and the discovery of novel chemical entities.
Used in Drug Development:
5-FLUORO-1-METHYL-1H-INDOLE-2-CARBOXYLIC ACID has potential applications in the development of new drugs, particularly in medicinal chemistry, where its properties can be leveraged to create innovative therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5-FLUORO-1-METHYL-1H-INDOLE-2-CARBOXYLIC ACID is used for its valuable properties that contribute to the advancement of drug discovery and the design of effective pharmaceuticals.
Used in Organic Synthesis:
5-FLUORO-1-METHYL-1H-INDOLE-2-CARBOXYLIC ACID is also applied in organic synthesis, where its reactivity and structural features are harnessed to produce a variety of organic compounds for various applications.

InChI:InChI=1/C10H8FNO2/c1-12-8-3-2-7(11)4-6(8)5-9(12)10(13)14/h2-5H,1H3,(H,13,14)

Upstream product

• 108797-28-0 ethyl 5-fluoro-1-methyl-1H-indole-2-carboxylate 

Downstream Products

• 168201-49-8 C₁₀H₇ClFNO 

Relevant academic research and scientific papers

New indole-isoxazolone derivatives: Synthesis, characterisation and in vitro SIRT1 inhibition studies

A new series of indole-isoxazolone hybrids bearing substituted amide, substituted [(1,2,3-triazol-4-yl)methoxy]methyl group or substituted benzylic ether at position-2 of the indole nucleus was synthesised using a facile synthetic route and the molecules

Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them

Benzo-fused heterocyclic compounds having a 5-membered ring, processes for their preperation, their use as medicaments, their use as diagnostic agents and medicaments containing them. Benzo-fused heterocyclic compounds having a 5-membered ring, of the formula I STR1 where X is N or CR(6); Y is oxygen, S or NR(7); A and B together are a bond or are both hydrogen, if, at the same time, X is CR(6) and Y is NR(7), one of the substituents R(1) to R(6) is a --CO--N=C(NH2)2 group; the other respective substituents R(1) to R(6) are H, Hal or alkyl; up to two of the other substituents R(1) to R(6) are CN, NO2, N3, (C1 -C4)-alkoxy, CF3 ; up to one of the other substituents is R(8)--Cn H2n --Z-- or phenyl; R(7) is H, alk(en)yl or R(8)--Cn H2n --, and pharmaceutically tolerated salts there of, are described. A process f or the preparation of the compounds I which comprises reacting a compound of the formula II STR2 in which one of the substituents R(1)' to R(5)' is a --CO--L group and L is a leaving group which can easily be replaced nucleophilically, with guanidine, and, if appropriate, converting the product into the pharmacologically tolerated salt, furthermore is also described.